Dupilumab Improves Health-Related Quality of Life and a Range of Symptoms in Patients With Eosinophilic Esophagitis.

Jonathan M SpergelMirna ChehadeEvan S DellonAlbert J BredenoordXian SunLila GlotfeltyArsalan ShabbirSarette T TiltonEilish McCann

Published in: The American journal of gastroenterology (2024)

Dupilumab reduced the impact of EoE on multiple aspects of HRQoL, patients' impression of dysphagia, and frequency and severity of symptoms beyond dysphagia in adults/adolescents with EoE.

Keyphrases

end stage renal disease
atopic dermatitis
chronic kidney disease
ejection fraction
newly diagnosed
physical activity
peritoneal dialysis
sleep quality